Sagimet Biosciences

SGMTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$683.046 M

$11.09 +2.69%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

-$51.0M

Loss-making

Shares outstanding

42,893,900

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#185MapLight TherapeuticsMPLT$703.4M
#186Zevra TherapeuticsZVRA$687.7M
#187Sagimet BiosciencesSGMT$683.0M
#188NeurogeneNGNE$672.4M
#189AltimmuneALT$663.3M

What if Sagimet Biosciences were worth as much as…

Open the what-if tool →

Gold $30.2T

$490,881.65

Per share 44,263× higher

Bitcoin $1.74T

$28,277.68

Per share 2,550× higher

Nvidia $5.52T

$89,554.53

Per share 8,075× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Sagimet Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.